两种血液净化方式对维持性血液透析伴高血压患者血压的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

陕西省科学技术厅计划发展项目(2012K1211)


Effects and mechanism of two hemodialysis methods on blood pressure in maintenance hemodialysis patients with hypertension
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨血液灌流与透析对维持性血液透析伴高血压患者的血压、血浆内皮素1(ET1)及瘦素(Lep)的影响,并对其机制作初步分析。方法 选取陕西省人民医院2016年3月~2017年2月行维持性血液透析伴高血压患者94例作为研究对象,根据血液透析方式不同将患者分为观察组与对照组,每组各47例,观察组采用血液灌流联合常规透析,对照组采用常规血液透析。比较两组患者血压水平、实验室血液指标、机体矿物质、骨代谢指标水平及生活质量变化情况。结果 对照组收缩压、舒张压治疗4、8、12周后稍低于治疗前(P>005),但观察组明显低于治疗前(P<005);治疗后同一时期,观察组收缩压、舒张压明显低于对照组(P<005);对照组治疗12周后 ET1 、Lep 水平明显高于治疗前(P<005),观察组治疗12周后ET1、Lep水平明显低于治疗前(P<005);治疗后同一时期,观察组ET1、Lep水平明显优于对照组(P<005)。治疗后,观察组患者C反应蛋白(CRP)、白介素6(IL6)指标水平下降幅度明显大于对照组(P<005);观察组患者治疗后Ca明显下降,P、PINP明显上升(P<005);观察组患者治疗后FGF23、iPTH、Ca、P、βCTX、PINP指标水平较治疗前均明显下降(P<005);观察组治疗后患者躯体功能、角色功能、情绪功能、认知功能、社会功能评分均明显高于对照组(P<005)。结论 血液灌流联合常规透析相对于常规血液透析更能有效降低维持性血液透析伴高血压患者的血压水平,并改善血浆ET1及Lep水平,但血液灌流联合常规透析对患者机体矿物质、骨代谢指标存在一定影响,在治疗过程中需要对患者采取相应预防措施。

    Abstract:

    【Abstract】 Objective To investigate the effect of hemoperfusion and dialysis on blood pressure, plasma ET1 and Lep levels in maintenance hemodialysis patients with longterm hypertension. Methods 94 patients of maintenance hemodialysis comlicated with long term hypertension in our hospital from March 2016 to February 2017 were selected. According to the different methods of hemodialysis, 94 patients were divided into routine hemodialysis group and blood perfusion combined routine dialysis group. The changes of blood pressure, laboratory blood parameters, body minerals, bone metabolism and quality of life were compared between the two groups. Results The systolic blood pressure and diastolic blood pressure at 4, 8 and 12 weeks in the hemodialysis group were slightly lower than those before treatment, but the difference was not statistically significant (P>005). The systolic blood pressure and diastolic blood pressure at 4, 8 and 12 weeks in Hemoperfusion combined with routine dialysis group were significantly lower than those in the conventional hemodialysis group (P<005). The levels of plasma endothelin1 (ET1) and leptin (Lep) were significantly higher in the conventional hemodialysis group after 12 weeks of treatment than those before treatment (P<005). The levels of ET1 and Lep in the hemoperfusion combined with conventional hemodialysis group after 12 weeks of treatment were significantly lower than those before treatment. At the same time after treatment, the levels of ET1 and Lep in hemoperfusion combined with conventional hemodialysis group were significantly lower than those in conventional hemodialysis group (P<005). After treatment, the levels of CRP and IL6 in the blood perfusion combined with the conventional dialysis group were significantly greater than that of the conventional hemodialysis group (P<005). After treatment, there were obvious changes in the indexes of FGF23, iPTH, Ca, P, βCTX and PINP in the blood perfusion combined with the conventional dialysis group with a decreased trend(P<005), and the indexes in the blood perfusion combined with the conventional dialysis group were lower than those in the routine hemodialysis group (P<005). The scores of role function, emotional function, cognitive function and social function in the blood perfusion combined with routine dialysis group were significantly higher than those of routine hemodialysis group(P<005). Conclusion Hemoperfusion combined with conventional dialysis can effectively reduce the blood pressure level in maintenance hemodialysis patients with longterm hypertension, and improve plasma ET1 and Lep levels, but the blood perfusion combined with conventional dialysis has a certain influence on the body mineral and bone metabolism index of the patients, and the corresponding preventive measures should be taken to the patients during the treatment.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-02-25
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司